The European Union is reportedly in talks to make advance purchase deals of potential COVID-19 vaccines with drugmakers Moderna (MRNA), Sanofi (SNY) and …
Moderna (MRNA) soared a further 16% in Tuesday’s after-market trading after the biotech announced the publication of an interim analysis of the open-label …
Moderna Inc. (MRNA) has entered into an agreement with Spain’s Laboratorios Farmacéuticos Rovi, S.
Moderna (MRNA) has announced that it has completed enrollment for its Phase 2 study of mRNA-1273, the company’s vaccine candidate against Covid-19. Shares …
Moderna Inc. (MRNA) said it entered into a collaboration with Catalent (CTLT) for large-scale, commercial manufacturing of its mRNA-based experimental vaccine candidate against …
Israel is in advanced talks to buy Moderna Inc.’s (MRNA) experimental coronavirus vaccine candidate, the country’s news portal Ynet reported.
Five companies have now been picked by the Trump administration as the most likely candidates to produce a coronavirus vaccine, The New York …
Moderna Inc. (MRNA) announced that it has started dosing the first patients in a Phase 2 study with its experimental mRNA-1273 vaccine candidate …
Moderna (MRNA) has now priced an underwritten public offering of 17,600,000 shares at a public offering price of $76 per share, before underwriting …
Shares in Moderna Inc. (MRNA) shot up 21% after the biotech company reported “positive” interim clinical data for its experimental coronavirus vaccine.
